Repository logoGCRIS
  • English
  • Türkçe
  • Русский
Log In
New user? Click here to register. Have you forgotten your password?
Home
Communities
Browse GCRIS
Entities
Overview
GCRIS Guide
  1. Home
  2. Browse by Author

Browsing by Author "Oktay, G."

Filter results by typing the first few letters
Now showing 1 - 3 of 3
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Conference Object
    The Antidepressant Sertraline Impairs Proliferation and Invasiveness of Human Glioblastoma Cells
    (Wiley, 2025) Keles, D.; Inanc-Surer, S.; Sipahi, M.; Erkan, E. P.; Ates, H.; Erbayraktar, Z.; Oktay, G.
  • Loading...
    Thumbnail Image
    Conference Object
    The Effects of Metabolic Drugs on Tumor Behaviour in Oral Squamous Cell Carcinoma
    (Wiley, 2021) Inanc-Surer, S.; Keleş Bartık, Didem; Sipahi, M.; Oktay, G.
    [Abstract Not Available]
  • Loading...
    Thumbnail Image
    Article
    Citation - WoS: 4
    Citation - Scopus: 4
    Tetracaine Downregulates Matrix Metalloproteinase Activity and Inhibits Invasiveness of Strongly Metastatic Mda-Mb Human Breast Cancer Cells
    (Elsevier Ireland Ltd, 2023) Keleş Bartık, Didem; Sipahi, M.; İnanç-Sürer; Djamgoz, M.B.; Oktay, G.; Keleş, Didem; İnanç-Sürer, Şeniz
    Tetracaine, a long-acting amino ester-type local anesthetic, prevents the initiation and propagation of action potentials by reversibly blocking voltage-gated sodium channels (VGSCs). These channels, which are highly expressed in several carcinomas (e.g. breast, prostate, colon and lung cancers) have been implicated in promoting metastatic behaviours. Recent evidence suggests that local anesthetics can suppress cancer progression. In this paper, we aimed to explore whether tetracaine would reduce the invasive characteristics of breast cancer cells. In a comparative approach, we used two cell lines of contracting metastatic potential: MDA-MB-231 (strongly metastatic) and MCF-7 (weakly metastatic). Tetracaine (50 μM and 75 μM) did not affect the proliferation of both MDA-MB-231 and MCF-7 cells. Importantly, tetracaine suppressed the migratory, invasive, and adhesive capacities of MDA-MB-231 cells; there was no effect on the motility of MCF-7 cells. Tetracaine treatment also significantly decreased the expression and activity levels of MMP-2 and MMP-9, whilst increasing TIMP-2 expression in MDA-MB-231 cells. On the other hand, VGSC α/Nav1.5 and VGSC-β1 mRNA and protein expression levels were not affected. We conclude that tetracaine has anti-invasive effects on breast cancer cells and may be exploited clinically, for example, in surgery and/or in combination therapies. © 2023 Elsevier B.V.
Repository logo
Collections
  • Scopus Collection
  • WoS Collection
  • TrDizin Collection
  • PubMed Collection
Entities
  • Research Outputs
  • Organizations
  • Researchers
  • Projects
  • Awards
  • Equipments
  • Events
About
  • Contact
  • GCRIS
  • Research Ecosystems
  • Feedback
  • OAI-PMH

Log in to GCRIS Dashboard

GCRIS Mobile

Download GCRIS Mobile on the App StoreGet GCRIS Mobile on Google Play

Powered by Research Ecosystems

  • Privacy policy
  • End User Agreement
  • Feedback